ヘルスケア、医薬、医療機器
カテゴリー
日本, アメリカ, ヨーロッパ, その他の国
地理的範囲
ビデオリンク
USD15,000,000.00
販売価格 (USD)
利用できません
通常実施権価格 (USD)
利用できません
専用実施権価格 (USD)
利用できません
通常実施権ロイヤリティレート %
販売、ライセンス種別
パテントファミリー
パテントファミリー数
譲受人 / 権利者
登録日(権利付与済みの場合)
特許公報の公開リンク
追加情報の詳細を見るにはIP Exchange Premiumアカウントにアップグレードする必要があります

FUTURISTIC SAFE INJECTION SYSTEM-2020 for COVID-19 Vaccination

特許 権利維持 While the entire humanity is cursed to fight with horrible global pandemic of COVID-19 and is putting herculean efforts in developing effective vaccine to curb the menace, we can’t ignore the fact that mass vaccination of vast global population essentially requires at least equal or greater number of safe, user-friendly, non-reusable, ergonomic syringes as the number of dosage to effectively prevent reuses of syringes at any cost. The reuse of dirty syringes is one of the most alarming drawback associated with the conventional syringes, which claims millions of lives every year. Besides, the Needle-Stick Injuries (NSI), the aspiration and injection of correct dosage, disposal of huge amount of medical waste thereby generated etc. etc. are also the matter of great concerns, which need to be addressed effectively. Our promising, disruptive and cutting-edge “Packaging-cum-Injection” technology completely replaces the need of packaging medicament in vials, ampoules etc. It provides a safe, rapid, low cost and hassle-free injection system, saves invaluable human-hours involved in normal injection procedure by avoiding several time-consuming steps such as aspiration of the correct dosage of medicament in conventional syringe from container to syringe, setting the correct dose, elimination of air bubble etc. etc.; completely avoids reuse of dirty needles, contamination of medicament during transfer, wastage of costly injectables etc. It cuts approximately 70% of hazardous bio-medical waste generated due to disposable syringes and also saves approximately 60-70% raw material used in the manufacturing of such syringes and drug-containers. Besides, it also saves a significant amount of storage, transport, distribution as well as the burden of care and carriage on health workers as this technology requires merely to carry a couple of re-usable injectors and the pack of intended numbers of pre-filled drug-cartridges for mass vaccination. It is compatible with WHO’s standards and guidelines.

$15,000,000 購入 仲介を申し込む 問い合わせ
photo 追加情報の詳細を見るにはIP Exchange PlusまたはIP Exchange Premiumアカウントにアップグレードする必要があります